机构:[1]University of Texas MD Anderson Cancer Center, Houston[2]Fudan University Cancer Hospital, Shanghai, Shanghai[3]Graduate School of Medicine, Osaka[4]Shikoku Cancer Center, Matsuyama[5]Clinico Anglo Americana, Lima[6]Kyorin University Hospital, Tokyo[7]Hebei Medical University Fourth Hospital, Shijiazhuang, Hebei河北医科大学第四医院[8]Asan Medical Center, Seoul[9]Christie NHS Foundation Trust, Manchester[10]Novartis Pharmaceuticals Corporation, Florham Park[11]Novartis Pharma AG, Basel[12]Novartis Pharmaceuticals Corporation, Florham Park[13]Seoul National University Hospital, Seoul
第一作者机构:[1]University of Texas MD Anderson Cancer Center, Houston
推荐引用方式(GB/T 7714):
Ajani Jaffer,Li Jin,Satoh Taroh,et al.QUALITY OF LIFE IN PATIENTS WITH ADVANCED GASTRIC CANCER ENROLLED IN THE INTERNATIONAL, PHASE 3 GRANITE-1 STUDY[J].ANNALS OF ONCOLOGY.2012,23:28-28.
APA:
Ajani, Jaffer,Li, Jin,Satoh, Taroh,Nishina, Tomohiro,Alarcon-Rozas, A....&Bang, Yung-Jue.(2012).QUALITY OF LIFE IN PATIENTS WITH ADVANCED GASTRIC CANCER ENROLLED IN THE INTERNATIONAL, PHASE 3 GRANITE-1 STUDY.ANNALS OF ONCOLOGY,23,
MLA:
Ajani, Jaffer,et al."QUALITY OF LIFE IN PATIENTS WITH ADVANCED GASTRIC CANCER ENROLLED IN THE INTERNATIONAL, PHASE 3 GRANITE-1 STUDY".ANNALS OF ONCOLOGY 23.(2012):28-28